FDA NDC Directory · JSON-LD · Markdown

Haloperidol decanoate

NDC 68001-657 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA211180
Dosage form / routeINJECTION · INTRAMUSCULAR
Active ingredientsHALOPERIDOL DECANOATE (50 mg/mL)
Marketing started20250612
Package count1

External sources

Source: openFDA. Public-domain (CC0).